跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
OTRIVIN JUNIOR NASAL SPRAY xylometazoline hydrochloride 0.5mg/mL pump actuated metered dose aerosol - TGA Drug Approval Details
Approvals
/
TGA
/
OTRIVIN JUNIOR NASAL SPRAY xylometazoline hydrochloride 0.5mg/mL pump actuated metered dose aerosol
Approved
STANDARD
OTRIVIN JUNIOR NASAL SPRAY xylometazoline hydrochloride 0.5mg/mL pump actuated metered dose aerosol
Haleon Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
913721bd1fc7f920
Company
Haleon Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
913721bd1fc7f920
Product Name
OTRIVIN JUNIOR NASAL SPRAY xylometazoline hydrochloride 0.5mg/mL pump actuated metered dose aerosol
Artg Id
142227
Artg Name
OTRIVIN JUNIOR NASAL SPRAY xylometazoline hydrochloride 0.5mg/mL pump actuated metered dose aerosol
Sponsor
Haleon Australia Pty Ltd
Company Detail Path
/organization/haleon-australia-pty-ltd
Artg Date
2007-07-17
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Consumer Medicine Info
http://www.ebs.tga.gov.au/ebs/picmi/picmirepository.nsf/pdf?OpenAgent=&id=CP-2023-CMI-01535-1
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
913721bd1fc7f920
Type
Standard
Back to TGA Approvals